"KIMSHEALTH is the foundation for good health and wellness! Since 2002, we have kept our patients at the heart of our care and have committed ourselves to providing quality and affordable healthcare. KIMSHEALTH cares for over 2.5 million local and international patients annually through our multidisciplinary team of over 900 doctors and 6,000 healthcare professionals in India, Bahrain, Oman, Saudi Arabia, Qatar and the UAE. Our national and international accreditations demonstrate some of the highest clinical success rates and signify our strict quality and safety standards."

During the past decade, Kerala Institute of Medical Sciences conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kerala Institute of Medical Sciences" #1 sponsor was "CymaBay Therapeutics, Inc." with 1 trials, followed by "Human Genome Sciences Inc." with 1 trials sponsored, "Northwestern University" with 1 trials sponsored, "Sandoz" with 1 trials sponsored and "St. John's Research Institute" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kerala Institute of Medical Sciences" #1 collaborator was "Cadila Pharnmaceuticals" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Indian Society of Critical Care Medicine" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Population Health Research Institute" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Kerala Institute of Medical Sciences" are "Acute Coronary Syndrome" (1 trials), "Anemia" (1 trials), "Cardiovascular Diseases" (1 trials), "Chronic Renal Insufficiency" (1 trials) and "Septic Shock" (1 trials). Many other conditions were trialed in "Kerala Institute of Medical Sciences" in a lesser frequency.

Most popular intervention types in "Kerala Institute of Medical Sciences" are "Drug" (4 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Actos" (1 trials), "Belimumab 1 mg/kg" (1 trials), "Belimumab 10 mg/kg" (1 trials) and "ERYPO" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kerala Institute of Medical Sciences" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Kerala Institute of Medical Sciences". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Kerala Institute of Medical Sciences, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kerala Institute of Medical Sciences, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".